Total words: 1941 | 2-word phrases: 499 | 3-word phrases: 577 | 4-word phrases: 610
PAGE INFO
Title | Try to keep the title under 60 characters (62 characters) Amarin Corp plc | Home | Clinical Stage pharmaceutical Company |
Description | Try to keep the meta description between 50 - 160 characters (129 characters) Amarin, a rapidly growing pharmaceutical cardiovascular care company, develops and markets treatments for cardiovascular disease. |
Keywords | Meta keywords are not recommended anymore (0 characters) |
H1 | No H1 tag on the page (0 characters) |
ONE WORD PHRASES 255 Words
# |
Keyword |
H1 |
Title |
Des |
Volume |
Position |
Suggest |
Frequency |
Density |
1 | amarin | | | | | | | 43 | 16.86% |
2 | a | | | | | | | 37 | 14.51% |
3 | to | | | | | | | 27 | 10.59% |
4 | and | | | | | | | 23 | 9.02% |
5 | cardiovascular | | | | | | | 21 | 8.24% |
6 | is | | | | | | | 19 | 7.45% |
7 | of | | | | | | | 18 | 7.06% |
8 | we | | | | | | | 14 | 5.49% |
9 | our | | | | | | | 14 | 5.49% |
10 | disease | | | | | | | 13 | 5.10% |
TWO WORD PHRASES 499 Words
# |
Keyword |
H1 |
Title |
Des |
Volume |
Position |
Suggest |
Frequency |
Density |
1 | cardiovascular disease | | | | | | | 12 | 2.40% |
2 | amarin is | | | | | | | 9 | 1.80% |
3 | on a | | | | | | | 8 | 1.60% |
4 | a leading | | | | | | | 8 | 1.60% |
5 | cause of | | | | | | | 8 | 1.60% |
6 | of death | | | | | | | 8 | 1.60% |
7 | about amarin | | | | | | | 8 | 1.60% |
8 | find out | | | | | | | 8 | 1.60% |
9 | where we | | | | | | | 7 | 1.40% |
10 | is a | | | | | | | 7 | 1.40% |
11 | being a | | | | | | | 6 | 1.20% |
12 | leading cause | | | | | | | 6 | 1.20% |
13 | from being | | | | | | | 5 | 1.00% |
14 | learn more | | | | | | | 5 | 1.00% |
15 | disease from | | | | | | | 5 | 1.00% |
16 | we are | | | | | | | 5 | 1.00% |
17 | more about | | | | | | | 5 | 1.00% |
18 | cardiovascular health | | | | | | | 5 | 1.00% |
19 | investor relations | | | | | | | 5 | 1.00% |
20 | a new | | | | | | | 4 | 0.80% |
THREE WORD PHRASES 577 Words
# |
Keyword |
H1 |
Title |
Des |
Volume |
Position |
Suggest |
Frequency |
Density |
1 | cause of death | | | | | | | 8 | 1.39% |
2 | being a leading | | | | | | | 6 | 1.04% |
3 | leading cause of | | | | | | | 6 | 1.04% |
4 | disease from being | | | | | | | 5 | 0.87% |
5 | from being a | | | | | | | 5 | 0.87% |
6 | a leading cause | | | | | | | 5 | 0.87% |
7 | vision to stop | | | | | | | 4 | 0.69% |
8 | amarin is a | | | | | | | 4 | 0.69% |
9 | cardiovascular disease from | | | | | | | 4 | 0.69% |
10 | of death worldwide | | | | | | | 4 | 0.69% |
11 | world find out | | | | | | | 3 | 0.52% |
12 | paradigm in cardiovascular | | | | | | | 3 | 0.52% |
13 | a bold vision | | | | | | | 3 | 0.52% |
14 | more about amarin | | | | | | | 3 | 0.52% |
15 | amarin buildingamarin building | | | | | | | 3 | 0.52% |
16 | learn more about | | | | | | | 3 | 0.52% |
17 | on a bold | | | | | | | 3 | 0.52% |
18 | cardiovascular disease amarin | | | | | | | 3 | 0.52% |
19 | address cardiovascular disease | | | | | | | 3 | 0.52% |
20 | a new paradigm | | | | | | | 3 | 0.52% |
21 | bold vision to | | | | | | | 3 | 0.52% |
22 | find out how | | | | | | | 3 | 0.52% |
23 | where we are | | | | | | | 3 | 0.52% |
24 | new paradigm in | | | | | | | 3 | 0.52% |
25 | stand for below | | | | | | | 2 | 0.35% |
26 | we stand for | | | | | | | 2 | 0.35% |
27 | about amarin amarin | | | | | | | 2 | 0.35% |
28 | amarin vision amarin | | | | | | | 2 | 0.35% |
29 | achieve this vision | | | | | | | 2 | 0.35% |
30 | envisions a world | | | | | | | 2 | 0.35% |
FOUR WORD PHRASES 610 Words
# |
Keyword |
H1 |
Title |
Des |
Volume |
Position |
Suggest |
Frequency |
Density |
1 | leading cause of death | | | | | | | 6 | 0.98% |
2 | being a leading cause | | | | | | | 5 | 0.82% |
3 | a leading cause of | | | | | | | 5 | 0.82% |
4 | from being a leading | | | | | | | 5 | 0.82% |
5 | disease from being a | | | | | | | 5 | 0.82% |
6 | cardiovascular disease from being | | | | | | | 4 | 0.66% |
7 | cause of death worldwide | | | | | | | 4 | 0.66% |
8 | on a bold vision | | | | | | | 3 | 0.49% |
9 | a new paradigm in | | | | | | | 3 | 0.49% |
10 | a bold vision to | | | | | | | 3 | 0.49% |
11 | bold vision to stop | | | | | | | 3 | 0.49% |
12 | where were going and | | | | | | | 2 | 0.33% |
13 | are where were going | | | | | | | 2 | 0.33% |
14 | as well as a | | | | | | | 2 | 0.33% |
15 | going and what we | | | | | | | 2 | 0.33% |
16 | we are where were | | | | | | | 2 | 0.33% |
17 | who we are where | | | | | | | 2 | 0.33% |
18 | about who we are | | | | | | | 2 | 0.33% |
19 | a healthier world find | | | | | | | 2 | 0.33% |
20 | were going and what | | | | | | | 2 | 0.33% |
21 | we stand for below | | | | | | | 2 | 0.33% |
22 | and what we stand | | | | | | | 2 | 0.33% |
23 | what we stand for | | | | | | | 2 | 0.33% |
24 | that create a healthier | | | | | | | 2 | 0.33% |
25 | performance and corporate commitments | | | | | | | 2 | 0.33% |
26 | amarin’s performance and corporate | | | | | | | 2 | 0.33% |
27 | learn more about amarin | | | | | | | 2 | 0.33% |
28 | more about amarin amarin | | | | | | | 2 | 0.33% |
29 | into amarin’s performance and | | | | | | | 2 | 0.33% |
30 | corporate governance gain new | | | | | | | 2 | 0.33% |
31 | create a healthier world | | | | | | | 2 | 0.33% |
32 | revolutionary solutions that create | | | | | | | 2 | 0.33% |
33 | solutions that create a | | | | | | | 2 | 0.33% |
34 | stock prices and stock | | | | | | | 2 | 0.33% |
35 | out how amarin has | | | | | | | 2 | 0.33% |
36 | been creating a new | | | | | | | 2 | 0.33% |
37 | creating a new paradigm | | | | | | | 2 | 0.33% |
38 | more than three decades | | | | | | | 2 | 0.33% |
39 | get to know amarin | | | | | | | 2 | 0.33% |
40 | well as a comprehensive | | | | | | | 2 | 0.33% |
EXTERNAL LINKS